• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number VBH091002A
Device Problems Detachment Of Device Component (1104); Unintended Collision (1429); Inadequacy of Device Shape and/or Size (1583); Failure to Advance (2524); Patient-Device Incompatibility (2682)
Patient Problems Hemorrhage/Bleeding (1888); Low Blood Pressure/ Hypotension (1914)
Event Date 09/10/2014
Event Type  Injury  
Event Description
On (b)(6) 2014, the patient underwent attempted treatment of a thoracic aortic aneurysm.It was reported the thoracic aorta was very tortuous consisting of four bends.It was also reported the patient had previously underwent treatment of an abdominal aortic aneurysm, and cook zenith® devices were implanted in the suprarenal aorta.An attempt was made to advance a 24 fr gore® dryseal sheath, but the sheath would not advance reportedly due to the patient¿s small access vessels (6.5¿7 mm).It was reported that after the sheath dilator was able to be inserted up to the limb of the zenith system, a conformable gore® tag® thoracic endoprosthesis was advanced without a sheath (barebacked).However, the device would not advance past the limb of the zenith system in the right common iliac artery.The gore® tag® device was removed from the patient, and a decision was reportedly made to cover the right external iliac artery with an iliac extender component and gore® viabahn endoprosthesis as a conduit.Both devices were reportedly ballooned with a 9 mm balloon for intentional contained rupture.The vessel reportedly stretched during ballooning but did not rupture.It was reported the gore® tag® device was then barebacked through the conduit, but the tag caught on the proximal bare metal portion of the zenith device.During reported multiple attempts to advance and manipulate the tag past the zenith device, the patient¿s blood pressure dropped and bleeding was reportedly noted from the right external iliac artery.It was reported the iliac extender component had become separated (amount unknown) from the viabahn during the forceful advancement of the tag, and the right external iliac artery had ruptured.It is reportedly unknown exactly when the rupture occurred.At that point, the tag was removed from the patient, and a second gore® viabahn® endoprosthesis was implanted as a bridge between the iliac extender and first viabahn to cover the rupture.It was reported the second viabahn was ballooned multiple times and a complete contained rupture was achieved as reportedly intended.The physician then barebacked the tag and was able to get the device past the zenith system and two of the bends in the thoracic aorta.It was reported that while the physician was attempting to advance the tag past the third bend in the thoracic aorta, the patient¿s blood pressure again dropped.It was reportedly determined the second gore® viabahn had moved proximally (amount unknown) due to the excessive torquing on the tag catheter during advancement, causing a separation between the iliac extender and viabahn devices.It was reported an occlusion balloon was advanced, the tag was removed, and a third gore® viabahn® endoprosthesis was implanted as a bridge between the previously placed devices in the iliac artery to cover the rupture.The device was then ballooned, and hemostasis was reportedly achieved with no bleeding noted.It was reported the physician was then able to bareback the tag past the zenith device, but the tag reportedly would not traverse past the third bend in the thoracic aorta.At that point, the physician elected to abort the procedure, and the tag was removed from the patient.It was reported the patient received 2 units of blood during the procedure due to the blood loss (amount unknown) from the rupture.There were reportedly no other clinical complications from the rupture other than the two episodes of hypotension.It was reported the patient left the operating room in stable condition.No further adverse events were reported.
 
Manufacturer Narrative
Brand name: medical devices - 24 fr gore® dryseal sheath, conformable gore® tag® thoracic endoprosthesis, iliac extender component, 9 mm balloon, gore® viabahn endoprosthesis (lot 12750861), gore® viabahn endoprosthesis (lot 10821557).Patient medications - aspirin, melatonin, trazodone, ranitidine, toprol, zestril, pepcid, fossamax, elavil, plavix, zyloprim, zocor, norvasc, prednisone, multivitamins, and vitamin d.The review of the manufacturing paperwork verified that this lot met all pre-release specifications.The imaging evaluation is currently in process.
 
Manufacturer Narrative
]results: imaging evaluation stated that the available images include a pre-implantation study.The images provided do not allow for evaluation in relation to migration or endoleak.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN® ENDOPROSTHESIS
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86001
Manufacturer Contact
sandra whicker
1500 n. 4th street
flagstaff, AZ 86004
9285263030
MDR Report Key4152839
MDR Text Key4909988
Report Number2017233-2014-00517
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/10/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/08/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/13/2017
Device Catalogue NumberVBH091002A
Device Lot Number12764893
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/24/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age87 YR
Patient Weight62
-
-